Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27552
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPetborom P.
dc.contributor.authorLimsirisawat W.
dc.contributor.authorKulpraneet M.
dc.contributor.authorRungruanghiranya S.
dc.contributor.authorPreedapornpakorn K.
dc.date.accessioned2022-12-14T03:17:37Z-
dc.date.available2022-12-14T03:17:37Z-
dc.date.issued2022
dc.identifier.issn1252208
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123306794&doi=10.35755%2fjmedassocthai.2022.S01.00009&partnerID=40&md5=11dcd57b3ecc6ef81fbdb5eeb380717a
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/27552-
dc.description.abstractBackground: Chronic obstructive pulmonary disease (COPD) is a disease that affecting body systems especially the respiratory system, circulatory system and also hematopoietic system. Objectives: The primary objective of the present study was to determine the prevalence of anemia and polycythemia in COPD patients. The secondary objectives was to determine factors associated with anemia and polycythemia. Materials and Methods: The present study was a retrospective study. All medical records of COPD patients visiting the lung diseases clinic of HRH Princess Maha Chakri Sirindhorn Medical Center between January 1, 2016, and December 31, 2019, were reviewed. Complete blood count, biochemistry laboratory results, lung function test, 6-minute walking distance, frequency of exacerbations and admission were recorded. Results: One hundred twenty-five patients were enrolled. Patients in GOLD stage 1, 2, 3 and 4 were 41.2%, 47%, 9.8% and 2% respectively. Most of the patients were in group A (50.4%). In our study, the prevalence of anemia in COPD patients was 39.2% and none of the patients had polycythemia. There was no association between GOLD classification or group of COPD and anemia. When analyzed by multiple logistic regression, we found that the higher BMI showed a significantly lower risk of anemia than lower BMI (OR 0.877; 95% CI: 0.795 to 0.967) and the frequency of acute exacerbation correlated with anemic condition statistically significant (OR 1.402, 95% CI: 1.142 to 1.721). Anemia and frequency of exacerbation had very low level of positive correlation (r=0.282) at the significance level. Conclusion: Anemia was common comorbidity in COPD patients. Lower body mass index and frequency of exacerbation were significantly related to anemia. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
dc.languageen
dc.subjectcholesterol
dc.subjectcreatinine
dc.subjecthemoglobin
dc.subjectprotein
dc.subjectserum albumin
dc.subjectserum globulin
dc.subjectaged
dc.subjectanemia
dc.subjectArticle
dc.subjectblood cell count
dc.subjectbody mass
dc.titleA Study of Red Blood Cell Disorders in Chronic Obstructive Pulmonary Disease Patients
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 105, No. (2022), p.S13-S18
dc.identifier.doi10.35755/jmedassocthai.2022.S01.00009
Appears in Collections:Scopus 2022

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.